ES2151850B1 - Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente. - Google Patents

Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.

Info

Publication number
ES2151850B1
ES2151850B1 ES009802240A ES9802240A ES2151850B1 ES 2151850 B1 ES2151850 B1 ES 2151850B1 ES 009802240 A ES009802240 A ES 009802240A ES 9802240 A ES9802240 A ES 9802240A ES 2151850 B1 ES2151850 B1 ES 2151850B1
Authority
ES
Spain
Prior art keywords
synthesis
corresponding use
chem
preparation
amlodipino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009802240A
Other languages
English (en)
Other versions
ES2151850A1 (es
Inventor
Laura Coppi
Guillen Yolanda Gasanz
Pardo Julio Campon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Quimica SA
Original Assignee
Esteve Quimica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009802240A priority Critical patent/ES2151850B1/es
Application filed by Esteve Quimica SA filed Critical Esteve Quimica SA
Priority to AT99952654T priority patent/ATE313526T1/de
Priority to AU64772/99A priority patent/AU752042B2/en
Priority to DE69929079T priority patent/DE69929079T2/de
Priority to EP99952654A priority patent/EP1125924B1/en
Priority to DK99952654T priority patent/DK1125924T3/da
Priority to JP2000578284A priority patent/JP2002528436A/ja
Priority to KR1020017005232A priority patent/KR100576166B1/ko
Priority to ES99952654T priority patent/ES2251843T3/es
Priority to CA002349013A priority patent/CA2349013C/en
Priority to SI9930870T priority patent/SI1125924T1/sl
Priority to PCT/ES1999/000333 priority patent/WO2000024714A1/es
Publication of ES2151850A1 publication Critical patent/ES2151850A1/es
Application granted granted Critical
Publication of ES2151850B1 publication Critical patent/ES2151850B1/es
Priority to US10/041,475 priority patent/US6603006B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Intermedio para la síntesis del amlodipino, procedimiento para su obtención y utilización correspondiente. El intermedio es el 3- amino-4-(2-ftalimido)etoxi)crotonato de etilo y es de fórmula III **FÓRMULA 1** El procedimiento para su obtención comprende la reacción del acetoacetato de fórmula **FÓRMULA 2** con acetato amónico; y su utilización es para la preparación del compuesto de fórmula **FÓRMULA 3** llevándose a cabo mediante la reacción del 3-amino-4-(2-ftalimido)etoxi)crotonato de etilo con un benciliden derivado.
ES009802240A 1998-10-26 1998-10-26 Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente. Expired - Fee Related ES2151850B1 (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ES009802240A ES2151850B1 (es) 1998-10-26 1998-10-26 Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
SI9930870T SI1125924T1 (sl) 1998-10-26 1999-10-18 Intermediat za sintezo amlodipina, postopek za pripravo in ustrezna uporaba
DE69929079T DE69929079T2 (de) 1998-10-26 1999-10-18 Zwischenstufe für die synthese von amlodipin, herstellungsverfahren und entsprechende anwendung
EP99952654A EP1125924B1 (en) 1998-10-26 1999-10-18 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
DK99952654T DK1125924T3 (da) 1998-10-26 1999-10-18 Mellemprodukt til syntesen af amlodipin, fremstillingsfremgangsmåde og tilsvarende anvendelse
JP2000578284A JP2002528436A (ja) 1998-10-26 1999-10-18 アムロジピン合成用中間体、その調製方法および使用方法
AT99952654T ATE313526T1 (de) 1998-10-26 1999-10-18 Zwischenstufe für die synthese von amlodipin, herstellungsverfahren und entsprechende anwendung
ES99952654T ES2251843T3 (es) 1998-10-26 1999-10-18 Intermedio para la sintesis del amlodipino, procedimiento para su obtencion y utilizacion correspondiente.
CA002349013A CA2349013C (en) 1998-10-26 1999-10-18 Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use
AU64772/99A AU752042B2 (en) 1998-10-26 1999-10-18 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
PCT/ES1999/000333 WO2000024714A1 (es) 1998-10-26 1999-10-18 Intermedio para la sintesis de amlodipino, procedimiento para su obtencion y utilizacion correspondiente
KR1020017005232A KR100576166B1 (ko) 1998-10-26 1999-10-18 아믈로디핀 합성을 위한 중간체, 이의 제조 방법 및 이의용도
US10/041,475 US6603006B2 (en) 1998-10-26 2002-01-10 Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802240A ES2151850B1 (es) 1998-10-26 1998-10-26 Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.

Publications (2)

Publication Number Publication Date
ES2151850A1 ES2151850A1 (es) 2001-01-01
ES2151850B1 true ES2151850B1 (es) 2001-08-16

Family

ID=8305582

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009802240A Expired - Fee Related ES2151850B1 (es) 1998-10-26 1998-10-26 Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
ES99952654T Expired - Lifetime ES2251843T3 (es) 1998-10-26 1999-10-18 Intermedio para la sintesis del amlodipino, procedimiento para su obtencion y utilizacion correspondiente.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99952654T Expired - Lifetime ES2251843T3 (es) 1998-10-26 1999-10-18 Intermedio para la sintesis del amlodipino, procedimiento para su obtencion y utilizacion correspondiente.

Country Status (12)

Country Link
US (1) US6603006B2 (es)
EP (1) EP1125924B1 (es)
JP (1) JP2002528436A (es)
KR (1) KR100576166B1 (es)
AT (1) ATE313526T1 (es)
AU (1) AU752042B2 (es)
CA (1) CA2349013C (es)
DE (1) DE69929079T2 (es)
DK (1) DK1125924T3 (es)
ES (2) ES2151850B1 (es)
SI (1) SI1125924T1 (es)
WO (1) WO2000024714A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0116554A (pt) 2000-12-29 2004-02-03 Pfizer Ltd Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
CA2433181C (en) 2000-12-29 2005-11-22 Pfizer Limited Amlodipine hemifumarate
DE60116514T2 (de) 2000-12-29 2006-08-17 Pfizer Ltd., Sandwich Amlodipinhemimaleat
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
EP1309555B1 (en) 2000-12-29 2005-07-27 Pfizer Limited Process for making amlodipine maleate
WO2002054062A2 (en) 2000-12-29 2002-07-11 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
BR0116553A (pt) 2000-12-29 2004-02-03 Pfizer Ltd Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
ES2211317B1 (es) * 2002-11-18 2005-10-16 Finaf 92, S.A. Compuestos intermedios para la obtencion de principios activos antihipertensivos y procedimientos correspondientes.
AU2004218241B2 (en) * 2003-03-07 2010-06-03 Syngenta Participations Ag Process for the production of substituted nicotinic acid esters
KR100807336B1 (ko) 2006-10-23 2008-02-28 명문제약주식회사 암로디핀의 제조를 위한 신규한 중간체 화합물, 이의 제조방법 및 이를 이용한 암로디핀의 제조 방법
JP2010100562A (ja) * 2008-10-23 2010-05-06 Daito Kk アムロジピン製造中間体の精製方法
EP3334485B1 (en) 2015-08-14 2024-03-06 ResMed Pty Ltd Monitoring respiratory pressure therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
PT77842B (en) * 1982-12-21 1986-05-05 Pfizer Process for preparing dihydropyridines
GB8422139D0 (en) * 1984-09-01 1984-10-03 Fisons Plc Biologically active nitrogen heterocyclics
AU7810087A (en) * 1986-08-14 1988-03-08 Byk Gulden Lomberg Chemische Fabrik Gmbh New piperidines
GB9119983D0 (en) * 1991-09-19 1991-11-06 Erba Carlo Spa Dihydropyridine derivatives useful in antitumor therapy

Also Published As

Publication number Publication date
DE69929079D1 (de) 2006-01-26
ATE313526T1 (de) 2006-01-15
CA2349013C (en) 2007-10-02
ES2251843T3 (es) 2006-05-01
KR20010093781A (ko) 2001-10-29
DE69929079T2 (de) 2006-06-22
JP2002528436A (ja) 2002-09-03
EP1125924A1 (en) 2001-08-22
CA2349013A1 (en) 2000-05-04
ES2151850A1 (es) 2001-01-01
SI1125924T1 (sl) 2006-04-30
AU6477299A (en) 2000-05-15
KR100576166B1 (ko) 2006-05-03
WO2000024714A1 (es) 2000-05-04
DK1125924T3 (da) 2006-05-08
EP1125924B1 (en) 2005-12-21
US20020068831A1 (en) 2002-06-06
AU752042B2 (en) 2002-09-05
US6603006B2 (en) 2003-08-05

Similar Documents

Publication Publication Date Title
ES2151850B1 (es) Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
DK0758335T3 (da) Fremstilling af et camptothecinderivat ved intramolekylær ringslutning
EA200101081A1 (ru) Способ получения циталопрама
CA2293709A1 (en) Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
EA200100213A1 (ru) Способ синтеза производных (1h)-бензо[c]хинолизин-3-онов
ES2145920T3 (es) Procedimiento de produccion de derivado de alcoxiiminoacetamida.
WO2003004459A3 (en) Process for the preparation of nitrile compounds
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
DE69629133D1 (de) Substituierte Aminochinazolinon (thion) Derivate
NO20010265L (no) 3-(1-hydroksy-pentyliden)-5-nitro-3H-benzofuran-2-on, fremgangsmåte for fremstilling og anvendelse derav
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
LV12185A (lv) 4-halogen-2'-nitrobutirofenona iegusanas panemiens
EP2194038A3 (en) Improved preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-P-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
DK0574952T3 (da) Fremgangsmåde til fremstilling af 2-oxopyrrolidinylacetamidderivater
DK0662475T3 (da) Fremgangsmåde til fremstilling af 2-perfluoralkyl-3-oxazolin-5-on.
WO2001083423A3 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
CA2284646A1 (en) Synthesis of intermediates useful in preparing tricyclic compounds
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
DK0506235T3 (da) Glyceraldehyd-3-pentanid og fremgangsmåde til fremstilling af samme
ATE264314T1 (de) Benzoxazol-derivate, verfahren zu ihrer herstellung und herbizide
KR970074762A (ko) 디티오카본이미드 유도체의 제조방법
AU6520498A (en) Process for producing piperidinecarboxylic acid amides
TR200001161A2 (tr) 8-Siklopentil-6-etil-3-[ikame edilmiş]-5, 8-Dihidro-4H-1, 2, 3A, 7, 8-Pentaaza-As-Indasenlerin hazırlandığı işlem ve burada yararlı ara bağlar.
AU7313300A (en) Process for the preparation of oxazole derivatives
IT1318465B1 (it) Processo per la preparazione di decaidro-2a, 4a,6a,8a-tetraazaciclopent(fg)acenaftilene e derivati funzionalizzati.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010101

Kind code of ref document: A1

Effective date: 20010101

FD2A Announcement of lapse in spain

Effective date: 20180807